Zhou Y - Search Results

1

Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin.

Hou G, Yang S, Zhou Y, Wang C, Zhao W, Lu Z. Hou G, et al. Among authors: zhou y. J Immunol Res. 2014;2014:845763. doi: 10.1155/2014/845763. Epub 2014 Apr 10. J Immunol Res. 2014. PMID: 24818169 Free PMC article.

2

Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma.

Tang JC, Chan D, Chung PY, Liu Y, Lam AK, Law S, Huang W, Chan AS, Lam KH, Zhou Y. Tang JC, et al. Among authors: zhou y. Int J Mol Med. 2024 Dec;54(6):111. doi: 10.3892/ijmm.2024.5435. Epub 2024 Oct 4. Int J Mol Med. 2024. PMID: 39364750 Free PMC article.

3

Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.

Guo L, Chen P, Zhou Y, Sun Y. Guo L, et al. Among authors: zhou y. Exp Mol Pathol. 2010 Jun;88(3):401-6. doi: 10.1016/j.yexmp.2010.02.003. Epub 2010 Mar 4. Exp Mol Pathol. 2010. PMID: 20206622

4

Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo.

Luo J, Zhu W, Tang Y, Cao H, Zhou Y, Ji R, Zhou X, Lu Z, Yang H, Zhang S, Cao J. Luo J, et al. Among authors: zhou x, zhou y. Radiat Oncol. 2014 Mar 25;9:84. doi: 10.1186/1748-717X-9-84. Radiat Oncol. 2014. PMID: 24666614 Free PMC article.

5

miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.

Lu J, Wang L, Chen W, Wang Y, Zhen S, Chen H, Cheng J, Zhou Y, Li X, Zhao L. Lu J, et al. Among authors: zhou y. Arch Biochem Biophys. 2019 Jan;661:1-9. doi: 10.1016/j.abb.2018.10.014. Epub 2018 Oct 23. Arch Biochem Biophys. 2019. PMID: 30365936

6

A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients.

Sun Y, Zhou Y, Bai Y, Wang Q, Bao J, Luo Y, Guo Y, Guo L. Sun Y, et al. Among authors: zhou y. Mol Cancer. 2017 Oct 17;16(1):162. doi: 10.1186/s12943-017-0729-1. Mol Cancer. 2017. PMID: 29041935 Free PMC article.

7

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer.

Lu J, Zhen S, Tuo X, Chang S, Yang X, Zhou Y, Chen W, Zhao L, Li X. Lu J, et al. Among authors: zhou y. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221110668. doi: 10.1177/15330338221110668. Technol Cancer Res Treat. 2022. PMID: 35770296 Free PMC article.

8

Butein sensitizes HeLa cells to cisplatin through the AKT and ERK/p38 MAPK pathways by targeting FoxO3a.

Zhang L, Yang X, Li X, Li C, Zhao L, Zhou Y, Hou H. Zhang L, et al. Among authors: zhou y. Int J Mol Med. 2015 Oct;36(4):957-66. doi: 10.3892/ijmm.2015.2324. Epub 2015 Aug 24. Int J Mol Med. 2015. PMID: 26310353 Free PMC article.

9

TET1 promotes cisplatin-resistance via demethylating the vimentin promoter in ovarian cancer.

Han X, Zhou Y, You Y, Lu J, Wang L, Hou H, Li J, Chen W, Zhao L, Li X. Han X, et al. Among authors: zhou y. Cell Biol Int. 2017 Apr;41(4):405-414. doi: 10.1002/cbin.10734. Epub 2017 Feb 16. Cell Biol Int. 2017. PMID: 28150354

10

The negative feedback between miR-143 and DNMT3A regulates cisplatin resistance in ovarian cancer.

Han X, Liu D, Zhou Y, Wang L, Hou H, Chen H, Zhang L, Chen W, Li X, Zhao L. Han X, et al. Among authors: zhou y. Cell Biol Int. 2021 Jan;45(1):227-237. doi: 10.1002/cbin.11486. Epub 2020 Oct 22. Cell Biol Int. 2021. PMID: 33090550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,517 results

Search Page

Filters